SCUTERI, DAMIANA
 Distribuzione geografica
Continente #
NA - Nord America 498
AS - Asia 369
EU - Europa 330
OC - Oceania 11
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 1.222
Nazione #
US - Stati Uniti d'America 481
SG - Singapore 287
IT - Italia 198
CN - Cina 57
GB - Regno Unito 35
DE - Germania 22
SE - Svezia 17
FI - Finlandia 15
CA - Canada 14
EE - Estonia 9
NL - Olanda 8
RU - Federazione Russa 8
HK - Hong Kong 6
IN - India 6
NZ - Nuova Zelanda 6
AT - Austria 5
AU - Australia 5
BR - Brasile 5
TW - Taiwan 5
EU - Europa 4
IE - Irlanda 4
MX - Messico 3
RO - Romania 3
TH - Thailandia 3
TR - Turchia 3
CL - Cile 2
CO - Colombia 2
FR - Francia 2
BD - Bangladesh 1
HR - Croazia 1
MD - Moldavia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
UA - Ucraina 1
Totale 1.222
Città #
Santa Clara 86
Singapore 78
Chandler 48
Lawrence 38
Princeton 38
Milan 34
Chicago 32
Ashburn 28
London 27
Wilmington 22
Catanzaro 19
Helsinki 14
Redwood City 12
Beijing 11
Des Moines 11
Ann Arbor 8
Birmingham 8
Ottawa 7
Palermo 7
Rome 7
Vallefiorita 7
Florence 6
Hong Kong 6
Shenzhen 6
St Petersburg 5
Amsterdam 4
Assago 4
Auckland 4
Guangzhou 4
Naples 4
Palizzi Marina 4
San Ferdinando 4
Shanghai 4
Taipei 4
Aversa 3
Bologna 3
Dublin 3
García 3
Hackney 3
Horia 3
Rende 3
Rizziconi 3
San Nicola Manfredi 3
Springfield 3
Toronto 3
Washington 3
Wuhan 3
Bangkok 2
Boardman 2
Bogotá 2
Buccinasco 2
Catania 2
Fort Worth 2
Haining 2
Istanbul 2
Livorno 2
Los Angeles 2
Melbourne 2
Mumbai 2
Munich 2
Muzaffarpur 2
Nuremberg 2
Porirua 2
Pune 2
San Gennaro Vesuviano 2
Siler City 2
São Paulo 2
Taranto 2
Vienna 2
Alexandria 1
Andover 1
Ankara 1
Bisignano 1
Bryansk 1
Cantù 1
Castrovillari 1
Chengdu 1
Chisinau 1
Cosenza 1
Dallas 1
Dhaka 1
Edmonton 1
Fiesole 1
Garden City 1
Gatchina 1
Gravina di Catania 1
Jiaxing 1
Lakeland 1
Lima 1
Lisbon 1
Lissone 1
Mistretta 1
Monza 1
Mountain View 1
Nagold 1
Nashville 1
Niagara Falls 1
Norwalk 1
Novokuznetsk 1
Perugia 1
Totale 715
Nome #
Benefits and risks associated with cannabis and cannabis derivatives use 54
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies. 43
Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs. 38
Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats. 37
Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence 36
Impact of nutraceuticals on glaucoma: A systematic review 31
Focus on zavegepant: the first intranasal third-generation gepant 29
Evidence on the neuroprotective properties of brimonidine in glaucoma 29
Pain assessment and treatment in dementia at the time of coronavirus disease covid-19 29
Aging brain: In search for better neurotherapeutics 27
Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues 26
The need for better access to pain treatment: learning from drug consumption trends in the USA. 24
Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach. 24
Antinociceptive effect of inhalation of the essential oil of bergamot in mice 23
Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms 22
Eptinezumab for the treatment of migraine 22
Efficacy of Essential Oils in Relieving Cancer Pain: A Systematic Review and Meta-Analysis 21
Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy 21
Effects of Aging on Formalin-Induced Pain Behavior and Analgesic Activity of Gabapentin in C57BL/6 Mice 21
Bergamot Essential Oil Attenuates Anxiety-Like Behaviour in Rats 21
Development and translation of nanobeo, a nanotechnology-based delivery system of bergamot essential oil deprived of furocumarins, in the control of agitation in severe dementia 21
Editorial: “Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation” 20
Analgesic Characteristics of NanoBEO Released by an Airless Dispenser for the Control of Agitation in Severe Dementia 19
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play 18
Essential oils for the control of the neuropsychiatric symptoms of dementia. A pharmacotechnological appraisal 18
TRANSLATION OF BERGAMOT ESSENTIAL OIL IN CLINICAL TRIAL FOR CONTROL OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA 18
Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine 18
New trends in pharmacological control of neuropsychiatric symptoms of dementia 18
Role of 5-HT1A receptor in the anxiolytic-relaxant effects of bergamot essential oil in rodent 17
Proposal of combination therapies to treat refractory chronic migraine 17
Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence 16
Pharmacokinetic interactions between herbal medicines and drugs: Their mechanisms and clinical relevance 16
Efficacy of essential oils in pain: A systematic review and meta-analysis of preclinical evidence 16
Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis 16
Bergamot rehabilitation AgaINst agitation in dementia (BRAINAID): Study protocol for a randomized, double-blind, placebo-controlled trial to assess the efficacy of furocoumarin-free bergamot loaded in a nanotechnology-based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia 16
Biphasic Hormetic-like Effect of Lebecetin, a C-type Lectin of Snake Venom, on Formalin-induced Inflammation in Mice 15
Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)—Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems 15
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy 15
Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy 14
Genetic variants of CGRP signaling pathway in migraine: impact on novel therapeutics 13
New trends in pain research: from basic research to clinical translation 13
Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy. 13
Pharmacotechnological Advances for Clinical Translation of Essential Oils for the Treatment of Pain and Agitation in Severe Dementia 12
Translational Value of the Transdermal Administration of Bergamot Essential Oil and of Its Fractions 12
Dementia and COVID-19: A Case Report and Literature Review on Pain Management 12
Targeting Neuroplasticity for the Management of Pain and Agitation in Alzheimer’s Disease via Bergamot Nanotherapy 12
Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia 12
Exploitation of thermal sensitivity and hyperalgesia in a mouse model of dystonia 12
Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety 12
Dementia therapeutics and cognitive rehabilitation 11
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol 11
Basic, Translational, and Clinical Research on Dementia 11
Essential oils-induced analgesia and related translation for the management of agitation in dementia 11
Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 11
PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation 11
Aging Brain: In Search of Better Neurotherapeutics 11
Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial 11
Unbiased research is needed for rational translation of essential oils in clinic 11
Effect of gabapentin in a neuropathic pain model in mice overexpressing human wild-type or human mutated torsin a 11
Motor behavior induced by bergamot essential oil in experimental tasks is differentially modulated by pretreatment with metabotropic glutamate receptor 2/3 or 5 antagonists 11
GABAA/Benzodiazepine Receptor Complex in the Dorsal Hippocampus Mediates the Effects of Chrysin on Anxiety-Like Behaviour in Female Rats 11
Real world considerations for newly approved CGRP receptor antagonists in migraine care 10
Aromatherapy in Stroke Patients: Is it Time to Begin? 10
Contribution of Histamine to Nociceptive Behaviors Induced by Intrathecally Administered Cholecystokinin-8 10
Role of Spinal Cholecystokinin Octapeptide, Nociceptin/Orphanin FQ, and Hemokinin-1 in Diabetic Allodynia 10
Behavioral Effects of Continuously Administered Bergamot Essential Oil on Mice With Partial Sciatic Nerve Ligation 10
Hericenone C attenuates the second phase of formalin-induced nociceptive behavior by suppressing the accumulation of CD11c-positive cells in the paw epidermis via phosphorylated P65 10
Pharmacological Treatment of Pain and Agitation in Severe Dementia and Responsiveness to Change of the Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) Pain Scale: Study Protocol 10
Pattern of triptans use: A retrospective prescription study in Calabria, Italy 10
Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing 10
ROBOCOP (ROBOtic Care of Poststroke Pain): Study Protocol for a Randomized Trial to Assess Robot-Assisted Functional and Motor Recovery and Impact on Poststroke Pain Development 9
Homo-AMPA in the periaqueductal grey modulates pain and rostral ventromedial medulla activity in diabetic neuropathic mice 9
CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review 9
Evaluation of putative differences in vessel density and flow area in normal tension and high-pressure glaucoma using OCT-angiography 8
Opioids Resistance in Chronic Pain Management 8
Benefits and risks associated with cannabis and cannabis derivatives use 8
Requirements for Translation in Clinical Trials of Aromatherapy: The Case of the Essential Oil of Bergamot (BEO) for Management of Agitation in Severe Dementia 8
Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis 7
Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia 7
Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab 7
Scopolamine-Induced Memory Impairment in Mice: Effects of PEA-OXA on Memory Retrieval and Hippocampal LTP 5
Epigenetic and nanotechnology alliance to fight stroke-induced brain damage 5
Exploitation of Autophagy Inducers in the Management of Dementia: A Systematic Review 5
Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders 4
Totale 1.345
Categoria #
all - tutte 18.883
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.883


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 0 1 8
2020/2021102 1 8 60 5 8 7 0 5 7 0 0 1
2021/2022122 4 1 2 13 5 22 9 21 6 15 23 1
2022/2023229 78 9 7 9 17 30 6 21 23 8 17 4
2023/2024194 44 18 14 10 14 45 7 6 4 5 24 3
2024/2025675 125 58 35 21 87 104 20 18 157 44 6 0
Totale 1.345